BOSTON: Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili Inc. (Nasdaq: AKLI) announced the signing of a definitive merger agreement to form a diversified, leading digital health company. Under the terms of the agreement, Akili shareholders will receive $0.4340 per share of common stock in cash.…